NASDAQ:INOV - Inovalon Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$10.10 -0.10 (-0.98 %)
(As of 07/19/2018 08:00 AM ET)
Previous Close$10.20
Today's Range$9.90 - $10.15
52-Week Range$8.90 - $17.80
Volume260,400 shs
Average Volume367,261 shs
Market Capitalization$1.55 billion
P/E Ratio43.91
Dividend YieldN/A
Inovalon logoInovalon Holdings, Inc., a technology company, provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry. The company's platform enables the assessment and enhancement of clinical and quality outcomes and financial performance. It serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. The company provides technology that supports approximately 500 healthcare organizations. Its platforms are informed by data pertaining to approximately 932,000 physicians; 455,000 clinical facilities; and approximately 240 million individuals and 37 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.

Receive INOV News and Ratings via Email

Sign-up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Data processing & preparation
SectorComputer and Technology


Debt-to-Equity Ratio0.31
Current Ratio4.48
Quick Ratio4.48


Trailing P/E Ratio43.91
Forward P/E Ratio53.16
P/E Growth3.76

Sales & Book Value

Annual Sales$449.36 million
Price / Sales3.42
Cash Flow$0.5948 per share
Price / Cash16.98
Book Value$4.47 per share
Price / Book2.26


EPS (Most Recent Fiscal Year)$0.23
Net Income$34.81 million
Net Margins3.20%
Return on Equity2.50%
Return on Assets1.62%


Outstanding Shares152,270,000
Market Cap$1,553.13

The Truth About Cryptocurrencies

Inovalon (NASDAQ:INOV) Frequently Asked Questions

What is Inovalon's stock symbol?

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

How were Inovalon's earnings last quarter?

Inovalon Holdings Inc (NASDAQ:INOV) issued its earnings results on Tuesday, May, 8th. The technology company reported ($0.04) EPS for the quarter, missing the Zacks' consensus estimate of $0.06 by $0.10. The technology company earned $92.76 million during the quarter, compared to the consensus estimate of $107.76 million. Inovalon had a return on equity of 2.50% and a net margin of 3.20%. Inovalon's revenue was down 14.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.07 earnings per share. View Inovalon's Earnings History.

What guidance has Inovalon issued on next quarter's earnings?

Inovalon updated its FY18 earnings guidance on Tuesday, May, 8th. The company provided earnings per share (EPS) guidance of $0.32-0.38 for the period, compared to the Thomson Reuters consensus estimate of $0.39. The company issued revenue guidance of $568-593 million, compared to the consensus revenue estimate of $576.37 million.

What price target have analysts set for INOV?

3 brokers have issued 12-month target prices for Inovalon's stock. Their predictions range from $10.00 to $14.00. On average, they expect Inovalon's share price to reach $12.00 in the next year. This suggests a possible upside of 18.8% from the stock's current price. View Analyst Ratings for Inovalon.

What is the consensus analysts' recommendation for Inovalon?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last year. There are currently 1 sell rating and 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Are investors shorting Inovalon?

Inovalon saw a increase in short interest in the month of June. As of June 15th, there was short interest totalling 9,609,673 shares, an increase of 26.0% from the May 31st total of 7,629,730 shares. Based on an average trading volume of 581,432 shares, the days-to-cover ratio is currently 16.5 days. Approximately 14.2% of the shares of the company are short sold. View Inovalon's Current Options Chain.

Who are some of Inovalon's key competitors?

Who are Inovalon's key executives?

Inovalon's management team includes the folowing people:
  • Keith R. Dunleavy, Chairman & CEO (Age 49)
  • Mr. Robert A. Wychulis, Pres (Age 63)
  • Mr. John Michael Burgin, Chief Product Officer (Age 44)
  • Mr. Jonathan R. Boldt, Interim Chief Financial Officer (Age 33)
  • Mr. Jason B. Capitel, Chief Operating Officer (Age 46)

When did Inovalon IPO?

(INOV) raised $500 million in an initial public offering (IPO) on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Has Inovalon been receiving favorable news coverage?

Headlines about INOV stock have trended somewhat positive recently, Accern reports. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Inovalon earned a news sentiment score of 0.20 on Accern's scale. They also assigned media coverage about the technology company an impact score of 44.76 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Who are Inovalon's major shareholders?

Inovalon's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Summit Partners L P (2.29%), Riverbridge Partners LLC (0.66%), Fox Run Management L.L.C. (0.01%) and Amalgamated Bank (0.01%). Company insiders that own Inovalon stock include Joseph R Rostock, Keith R Dunleavy, Lee D Roberts, Robert A Wychulis, Shauna L Vernal, Thomas R Kloster, William D Green and William J Teuber Jr. View Institutional Ownership Trends for Inovalon.

Which major investors are selling Inovalon stock?

INOV stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC and Fox Run Management L.L.C.. Company insiders that have sold Inovalon company stock in the last year include Robert A Wychulis and Shauna L Vernal. View Insider Buying and Selling for Inovalon.

Which major investors are buying Inovalon stock?

INOV stock was bought by a variety of institutional investors in the last quarter, including Summit Partners L P and Amalgamated Bank. Company insiders that have bought Inovalon stock in the last two years include Keith R Dunleavy, Lee D Roberts, Robert A Wychulis, William D Green and William J Teuber Jr. View Insider Buying and Selling for Inovalon.

How do I buy shares of Inovalon?

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Inovalon's stock price today?

One share of INOV stock can currently be purchased for approximately $10.10.

How big of a company is Inovalon?

Inovalon has a market capitalization of $1.55 billion and generates $449.36 million in revenue each year. The technology company earns $34.81 million in net income (profit) each year or $0.23 on an earnings per share basis. Inovalon employs 2,480 workers across the globe.

How can I contact Inovalon?

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]

MarketBeat Community Rating for Inovalon (NASDAQ INOV)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  172 (Vote Outperform)
Underperform Votes:  230 (Vote Underperform)
Total Votes:  402
MarketBeat's community ratings are surveys of what our community members think about Inovalon and other stocks. Vote "Outperform" if you believe INOV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INOV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/19/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.